These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 36189203)

  • 1. Prospects of animal models and their application in studies on adaptive immunity to SARS-CoV-2.
    Wei X; Rong N; Liu J
    Front Immunol; 2022; 13():993754. PubMed ID: 36189203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nirmatrelvir treatment of SARS-CoV-2-infected mice blunts antiviral adaptive immune responses.
    Fumagalli V; Di Lucia P; Ravà M; Marotta D; Bono E; Grassi S; Donnici L; Cannalire R; Stefanelli I; Ferraro A; Esposito F; Pariani E; Inverso D; Montesano C; Delbue S; Perlman S; Tramontano E; De Francesco R; Summa V; Guidotti LG; Iannacone M
    EMBO Mol Med; 2023 May; 15(5):e17580. PubMed ID: 36946379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on host immunity correlates and prospects of re-infection in COVID-19.
    Negi N; Maurya SP; Singh R; Das BK
    Int Rev Immunol; 2022; 41(4):367-392. PubMed ID: 34961403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques.
    White AD; Sibley L; Sarfas C; Morrison AL; Bewley K; Churchward C; Fotheringham S; Gkolfinos K; Gooch K; Handley A; Humphries HE; Hunter L; Kennard C; Longet S; Mabbutt A; Moffatt M; Rayner E; Tipton T; Watson R; Hall Y; Bodman-Smith M; Gleeson F; Dennis M; Salguero FJ; Carroll M; McShane H; Cookson W; Hopkin J; Sharpe S
    Front Immunol; 2021; 12():801799. PubMed ID: 35222355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives.
    Boechat JL; Chora I; Morais A; Delgado L
    Pulmonology; 2021; 27(5):423-437. PubMed ID: 33867315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse models in COVID-19 research: analyzing the adaptive immune response.
    Clever S; Volz A
    Med Microbiol Immunol; 2023 Apr; 212(2):165-183. PubMed ID: 35661253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate and adaptive immunity to SARS-CoV-2 and predisposing factors.
    Shen J; Fan J; Zhao Y; Jiang D; Niu Z; Zhang Z; Cao G
    Front Immunol; 2023; 14():1159326. PubMed ID: 37228604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of SARS-CoV-2 nucleocapsid protein in antiviral immunity and vaccine development.
    Yu H; Guan F; Miller H; Lei J; Liu C
    Emerg Microbes Infect; 2023 Dec; 12(1):e2164219. PubMed ID: 36583642
    [No Abstract]   [Full Text] [Related]  

  • 9. Adaptive Immune Responses and Immunity to SARS-CoV-2.
    Primorac D; Vrdoljak K; Brlek P; Pavelić E; Molnar V; Matišić V; Erceg Ivkošić I; Parčina M
    Front Immunol; 2022; 13():848582. PubMed ID: 35603211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired innate antiviral defenses in COVID-19: Causes, consequences and therapeutic opportunities.
    Galani IE; Andreakos E
    Semin Immunol; 2021 Jun; 55():101522. PubMed ID: 34815163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cells in COVID-19 immunopathogenesis: insights for a possible role in determining disease outcome.
    Borges RC; Hohmann MS; Borghi SM
    Int Rev Immunol; 2021; 40(1-2):108-125. PubMed ID: 33191813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status in cellular-based therapies for prevention and treatment of COVID-19.
    Hattab D; Amer MFA; Mohd Gazzali A; Chuah LH; Bakhtiar A
    Crit Rev Clin Lab Sci; 2023 Aug; 60(5):321-345. PubMed ID: 36825325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular mechanism of SARS-CoV-2 evading host antiviral innate immunity.
    Gu W; Gan H; Ma Y; Xu L; Cheng ZJ; Li B; Zhang X; Jiang W; Sun J; Sun B; Hao C
    Virol J; 2022 Mar; 19(1):49. PubMed ID: 35305698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-cell analysis of the adaptive immune response to SARS-CoV-2 infection and vaccination.
    Qi F; Cao Y; Zhang S; Zhang Z
    Front Immunol; 2022; 13():964976. PubMed ID: 36119105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observations and Perspectives on Adaptive Immunity to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Dan J; da Silva Antunes R; Grifoni A; Weiskopf D; Crotty S; Sette A
    Clin Infect Dis; 2022 Aug; 75(Suppl 1):S24-S29. PubMed ID: 35441229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adaptive immunity against SARS-CoV-2].
    Combadière B
    Med Sci (Paris); 2020 Oct; 36(10):908-913. PubMed ID: 32960167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunopathogenesis and immunobiology of SARS-CoV-2.
    Rabaan AA; Al-Ahmed SH; Al Mutair A; Alhumaid S; Sule AA; Tirupathi R; Fawzy M; Muhammad J; Khan A; Hasan A; Shrestha DB; Sah R; Dhawan M; Tiwari R; Bilal M; Ahmad T; Dhama K
    Infez Med; 2021 Jun; 29(2):167-180. PubMed ID: 34061781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioengineered
    Chakraborty J; Banerjee I; Vaishya R; Ghosh S
    ACS Biomater Sci Eng; 2020 Dec; 6(12):6540-6555. PubMed ID: 33320635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response scenario and vaccine development for SARS-CoV-2 infection.
    Mohammad MHS
    Int Immunopharmacol; 2021 May; 94():107439. PubMed ID: 33571745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.